The change in FIB-4 in Japanese patients with type 2 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide (IDegLira)
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000051180
- Lead Sponsor
- Edogawa Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 137
Inclusion Criteria
Not provided
Exclusion Criteria
IDegLira was started at dose >16 dose steps IDegLira had already been administered at the initial consultation Antidiabetic agents other than IDegLira were changed during observation period Patients who discontinued treatment during observation period Patients who were transport to other hospitals during observation period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method